Terms: = Lymphoma AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E
753 results:
1. Plexiform Fibromyxoma in the Stomach: Immunohistochemical Profile and Comprehensive Genetic Characterization.
Di Mauro A; Rega RA; Leongito M; Albino V; Palaia R; Gualandi A; Belli A; D'Arbitrio I; Moccia P; Tafuto S; De Chiara A; Ottaiano A; Ferrara G
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732067
[TBL] [Abstract] [Full Text] [Related]
2. TP53 mutation is frequent in mantle cell lymphoma with EZH2 expression and have dismal outcome when both are present.
Kim DH; Siddiqui S; Jain P; Wang M; Thakral B; Li S; Miranda R; Vega F; Medeiros LJ; Ok CY
Hum Pathol; 2024 Apr; 146():1-7. PubMed ID: 38460798
[TBL] [Abstract] [Full Text] [Related]
3. Optical genomic mapping is a helpful tool for detecting ccnd1 rearrangements in CD5-negative small B-cell lymphoma: Two cases of leukemic non-nodal mantle cell lymphoma.
Quesada AE; Hu S; Li S; Toruner GA; Wei Q; Loghavi S; Ok CY; Jain P; Thakral B; Nwogbo OV; Kim D; Iyer SP; You MJ; Medeiros LJ; Tang G
Hum Pathol; 2024 Feb; 144():71-76. PubMed ID: 38301962
[TBL] [Abstract] [Full Text] [Related]
4. lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis.
Knauft J; Schenk T; Ernst T; Schnetzke U; Hochhaus A; La Rosée P; Birndt S
Leukemia; 2024 Feb; 38(2):235-249. PubMed ID: 38238443
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological and genetic landscape of plasmablastic lymphoma in Taiwan.
Chen BJ; Hsieh TH; Yuan CT; Wang RC; Yang CF; Chuang WY; Su YZ; Ho CH; Lin CH; Chuang SS
Pathol Res Pract; 2024 Jan; 253():155059. PubMed ID: 38160484
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of Clinical and Genetic Characteristics Between Younger and Older Lung Cancer Patients.
Candal-Pedreira C; Ruano-Ravina A; Calvo de Juan V; Cobo M; Trigo JM; Rodríguez-Abreu D; Estival A; Carcereny E; Cucurull M; López Castro R; Medina A; García Campelo R; Cordeiro González P; Sánchez-Gastaldo A; Bosch-Barrera J; Massutí B; Dómine M; Camps C; Ortega AL; Sánchez-Hernández A; Guirado Risueño M; Del Barco Morillo E; Garrido Fernández A; Provencio M
Arch Bronconeumol; 2024 Feb; 60(2):88-94. PubMed ID: 38160163
[TBL] [Abstract] [Full Text] [Related]
7. SOX11+ Large B-Cell Neoplasms: Cyclin D1-Negative Blastoid/Pleomorphic Mantle Cell lymphoma or Large B-Cell lymphoma?
Li S; Tang G; Jain P; Lin P; Xu J; Miranda RN; Cheng J; Yin CC; You MJ; Wang ML; Medeiros LJ
Mod Pathol; 2024 Feb; 37(2):100405. PubMed ID: 38104893
[TBL] [Abstract] [Full Text] [Related]
8. [Comprehensive Diagnosis of Mantle Cell lymphoma].
Yang H; Guo R; Shi Y; Wang R; Qiao C; Wu YJ; Fan L; Xu W; Li JY; Qiu HR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1720-1725. PubMed ID: 38071051
[TBL] [Abstract] [Full Text] [Related]
9. Recent advances in genomics and therapeutics in mantle cell lymphoma.
Lu T; Zhang J; McCracken JM; Young KH
Cancer Treat Rev; 2024 Jan; 122():102651. PubMed ID: 37976759
[TBL] [Abstract] [Full Text] [Related]
10. Illuminating (HTLV-1)-induced adult T-cell leukemia/lymphoma transcriptomic signature: A systems virology approach.
Forghani-Ramandi MM; Mostafavi B; Bahavar A; Dehghankar M; Siami Z; Mozhgani SH
Virus Res; 2023 Dec; 338():199237. PubMed ID: 37832654
[TBL] [Abstract] [Full Text] [Related]
11. Serum anti-tissue transglutaminase IgA and prediction of duodenal villous atrophy in adults with suspected coeliac disease without IgA deficiency (Bi.A.CeD): a multicentre, prospective cohort study.
Ciacci C; Bai JC; Holmes G; Al-Toma A; Biagi F; Carroccio A; Ciccocioppo R; Di Sabatino A; Gingold-Belfer R; Jinga M; Makharia G; Niveloni S; Norman GL; Rostami K; Sanders DS; Smecuol E; Villanacci V; Vivas S; Zingone F;
Lancet Gastroenterol Hepatol; 2023 Nov; 8(11):1005-1014. PubMed ID: 37696284
[TBL] [Abstract] [Full Text] [Related]
12. Toward Cytogenomics: Technical Assessment of Long-Read Nanopore Whole-Genome Sequencing for Detecting Large Chromosomal Alterations in Mantle Cell lymphoma.
Hansen MH; Cédile O; Kjeldsen MLG; Thomassen M; Preiss B; von Neuhoff N; Abildgaard N; Nyvold CG
J Mol Diagn; 2023 Nov; 25(11):796-805. PubMed ID: 37683892
[TBL] [Abstract] [Full Text] [Related]
13. Sequencing-based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy.
Karolová J; Kazantsev D; Svatoň M; Tušková L; Forsterová K; Maláriková D; Benešová K; Heizer T; Dolníková A; Klánová M; Winkovska L; Svobodová K; Hojný J; Krkavcová E; Froňková E; Zemanová Z; Trněný M; Klener P
Am J Hematol; 2023 Oct; 98(10):1627-1636. PubMed ID: 37605345
[TBL] [Abstract] [Full Text] [Related]
14. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
Quintanilla-Martinez L; Laurent C; Soma L; Ng SB; Climent F; Ondrejka SL; Zamo A; Wotherspoon A; de Leval L; Dirnhofer S; Leoncini L
Virchows Arch; 2023 Sep; 483(3):281-298. PubMed ID: 37555980
[TBL] [Abstract] [Full Text] [Related]
15. NFE2L2 and STAT3 Converge on Common Targets to Promote Survival of Primary lymphoma Cells.
Arena A; Di Crosta M; Gonnella R; Zarrella R; Romeo MA; Benedetti R; Gilardini Montani MS; Santarelli R; D'Orazi G; Cirone M
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511362
[TBL] [Abstract] [Full Text] [Related]
16. NOTCH Signaling in Mantle Cell lymphoma: Biological and Clinical Implications.
Deshotels L; Safa FM; Saba NS
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373427
[TBL] [Abstract] [Full Text] [Related]
17. Immunochemotherapy for life-threatening haematological malignancies in pregnancy: a systematic review of the literature and cross-sectional analysis of clinical trial eligibility.
Mills GS; Chadwick V; Tang C; Perram J; Anderson MA; Anazodo A; Kidson-Gerber G; Shand A; Lavee O; Withers B; Milliken S; Di Ciaccio PR; Hamad N
Lancet Haematol; 2023 Jun; 10(6):e458-e467. PubMed ID: 37263722
[TBL] [Abstract] [Full Text] [Related]
18. Utility of Measurable Residual Disease (MRD) Assessment in Mantle Cell lymphoma.
Wu S; Blombery P; Westerman D; Tam CS
Curr Treat Options Oncol; 2023 Aug; 24(8):929-947. PubMed ID: 37249800
[TBL] [Abstract] [Full Text] [Related]
19. Comprehensive FISH testing using FFPE tissue microarray of primary lymph node tissue identifies secondary cytogenetic abnormalities in Mantle Cell lymphoma.
Webb F; Morey A; Mahler-Hinder C; Georgousopoulou E; Koo R; Pati N; Talaulikar D
Cancer Genet; 2023 Jun; 274-275():75-83. PubMed ID: 37094546
[TBL] [Abstract] [Full Text] [Related]
20. Retrospective Analysis With Propensity Score Matching of Peripheral T-Cell lymphoma Treated Frontline With Brentuximab Vedotin and Chemotherapy.
Burke JM; Liu N; Yu KS; Fanale MA; Surinach A; Flores C; Lisano J; Phillips T
Oncologist; 2023 Jun; 28(6):520-530. PubMed ID: 36971492
[TBL] [Abstract] [Full Text] [Related]
[Next]
